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Summary 
Mercy Corp, through its resettlement program (EU-MRSI & RESTART), has begun resettling 
Roma, Ashali, and Egyptian (RAE) families living in internally displaced persons (IDP) camps 
in North Mitrovica to the historic Roma neighborhood (Roma Mahola) that had been destroyed 
during the war with Serbia in 1999. The IDP camps were heavily contaminated with lead, and 
many of the children living in them were lead-poisoned. Mercy Corp is carrying out this task 
with the financial support of the European Commission Liaison Office to Kosovo (ECLO) and 
the US Agency for International Development (USAID). This is a report of the status of 
identification and clinical care of the children who are less than 6 years old and have been 
relocated. The report contains recommendations for next steps to be taken in addressing the 
needs of these children. 
 
Status 
 Staff members at the Family Medicine Center in South Mitrovica have received several 
rounds of training. These staff members are welcome to consult with US experts at the 
Centers for Disease Control and Prevention (CDC) and the Montefiore Lead Treatment 
Referral Center in New York City regarding difficult cases. 
 
 There is a need for establishment of a regional referral laboratory at the Institute of Public 
Health (IPH) in Pristina. Such a laboratory should be equipped with a new graphite 
furnace atomic absorption spectrophometer (GFAAS). Pending the establishment of 
such a regional referral laboratory, the present IPH laboratory should become certified in 
blood lead testing by use of the existing GFAAS. 
 
Background 
Lead is a potent neurotoxicant. It can cause death at high blood lead levels, and at lower blood 
lead levels, it negatively affects neurodevelopment, IQ, and behavior. Children and fetuses are 
most sensitive to the adverse effects. No safe blood lead level for children has been identified. In 
addition, lead freely crosses the placenta, thus exposing the fetus to maternal blood lead levels. 
Maternal blood lead levels reflect both current exposure to lead and lead from previous exposure 
that is released from bone storage as the body mobilizes bones to meet fetal calcium demands.  
 
In June 2005, reports of symptomatic lead poisoning among children in Mitrovica, Kosovo 
reached the US Centers for Disease Control and Prevention (CDC). CDC has been an active 
participant in efforts to resolve the continuing tragedy of child lead poisoning in Kosovo since 
2005. 
 
The Roma whose homes were destroyed during the war were relocated to camps on land 
contaminated with lead and other heavy metals near the Trepca smelter in Mitrovica. Adding to 
the lead exposure is the fact that the Roma engage in informal smelting of car batteries and 
computers.  
 
Initial blood lead testing of children in the three IDP camps—Cesmin Lug, Kablar, and 
Zitkovac/Zhikoc—indicated that all children had blood lead levels (BLLs) > 65 µg/dL, the 
highest value reported by the hand-held Lead Care analyzer. As a result of these high readings, in 
July 2005 the World Health Organization (WHO) and the United Nations International 
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Children’s Emergency Fund (UNICEF) requested assistance from CDC. Specifically, CDC was 
asked to make recommendations for 1) a medical facility to identify and treat children with lead 
poisoning, 2) outreach and health education to the affected community, and 3) a strategy for 
primary prevention of childhood lead poisoning.  
 
During a five-day visit in August 2005, CDC staff met with Roma community leaders, 
representatives from nongovernmental organizations (NGOs), and officials from Albania, Serbia, 
and United Nations agencies to discuss current and planned activities related to lead exposure 
and prevention of lead poisoning. The outcome of this meeting was production of a detailed plan 
for a treatment facility for those exposed to heavy metals, and the plan was provided to WHO 
and UNICEF. CDC continued to maintain contact with these agencies, providing technical 
assistance and support as needed through telephone calls and e-mail. 
 
In January 2006, the Kosovo Office of UNICEF invited CDC to revisit the Mitrovica area. The 
main objectives of the two-week visit in January 2006 were to 1) review the status of progress on 
the CDC recommendations for BLL surveillance and medical treatment of children with lead 
poisoning; 2) assist in the efforts to assess and remediate lead hazards in the three Roma camps 
(Cesmin Lug, Kablar,and Zitkovac/Zhikoc); and 3) evaluate the lead hazards at the proposed 
new camp location at Osterode. The initial inspection of the Osterode camp determined that the 
camp was lead-safe. As a result, United Nations Mission in Kosovo (UNMK) requested and 
received US $1 million from the US Office in Pristina (USOP) to set up a medical treatment 
facility at the Osterode camp. CDC continued to provide technical assistance and support 
regarding treating lead poisoning among Roma children and preventing lead exposure. 
  
In August 2006, two laboratorians from the WHO-sponsored Institute of Public Health (IPH) in 
Pristina came to the Environmental Health Laboratory at CDC’s National Center for 
Environmental Health to be trained in the use of graphite furnace atomic absorption 
spectrophotometery for blood lead analysis. Since the visit of these two laboratorians, the 
laboratory in Pristina has participated in a quality assurance and control program at CDC. The 
results of CDC’s Laboratory Quality Assurance testing indicate that the laboratory in Pristina 
meets standards for blood lead testing laboratories established in Europe and the United States.  
 
In May 2007, as a result of continued concern about the clinical services provided by the 
treatment unit in Osterode camp, the US State Department, USOP, and USAID requested that 
CDC inspect the facility and make recommendations about future activities. Later in 2007, CDC 
travelled to Montenegro to work with WHO on the preparation of a manuscript describing the 
results of lead poisoning prevention interventions undertaken in the IDP camps (Brown et al. 
2009). In 2009, CDC conducted training of medical and community health staff in Macedonia. 
Later that year, CDC also undertook training of outreach, nursing, and medical staff at the 
Family Medical Unit in South Mitrovicia and at the Osterode camp. In 2010, CDC sponsored a 
week-long, hands-on training session for the laboratory and clinical staff members. The training 
occurred in New York City at the CDC lead poisoning prevention program and the Montefiore 
Lead Poisoning Referral Center.  
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 In December 2010, CDC provided support and technical assistance to clinical staff at Mercy 
Corp and the health center (Ambulanta) in South Mitrovicia. What follows is a description of the 
status of the clinical services now available and recommendations for next steps.  
 
Relocation Efforts 
In 2005 and 2006, the Danish Refugee Council and others participated in resettling over 80 
families from the IDP camps in North Mitrovicia and other locations to the Roma Mahola in 
South Mitrovicia.  
 
In 2010, the European Community Liaison Office (ECLO) and the US Agency for International 
Development (USAID) provided funding to relocate another 140 Roma families from the IDP 
camps Cesmin Lug and Osterode in North Mitrovica to the Roma Mahola in South Mitrovicia. In 
September 2010, 50 families were relocated from the Cesmin Lug/Osterode camps. At the end of 
September, the remaining families from Cesmin Lug were temporarily moved to Osterode, and 
the camp at Cesmin Lug was destroyed. Osterode was safer than than Cesmin Lug, but far from 
lead-free. Another 78 families with 71 children 6 years old and younger remained in the 
Osterode camp. A total of 38 Osterode families with 38 children 6 years old and younger were 
due to move to Roma Mahola on 20/12/2010. The remaining 40 Osterode families are expected 
to be relocated in 2011. When all families have been relocated, the Osterode facility can be 
destroyed (estimated July 2011). 
 
Blood Lead Laboratory Analysis 
Making the clinical diagnosis of lead poisoning can be difficult when there is no clear history of 
exposure. Poisoned children may be asymptomatic, and signs and symptoms, when they are 
present, are relatively non-specific. Blood lead level (BLL) tests are the only reliable way to 
diagnose lead-exposed individuals. Such tests are essential to the identification and management 
of lead poisoning. 
 
Several methods are available to determine BLLs. The most common ones are graphite furnace 
atomic absorption spectrometry (GFAAS), anodic stripping voltametry (ASV), and inductively 
coupled plasma mass spectrometry (ICP-MS). In addition, a simple-to-use, portable device using 
ASV technology is available for performing blood lead measurements at point-of-care (Lead 
Care 1 and Lead Care 2). These methods differ significantly in their analytical capacities (e.g., in 
limits of detection, accuracy), costs (e.g., purchase and maintenance costs, infrastructure 
required, reagents, and laboratory supplies), and technical requirements (e.g., sample 
preparation, calibration, need for skilled personnel).  
 
Currently, Lead Care 1 is used in the Roma Mahalla Ambulanta to test BLLs. However, the 
instrument is not working well, and the staff are awaiting receipt of Lead Care 2 technology. 
Such point-of-care instruments are useful for screening and follow-up of individual children. 
However, there is a need for more precise instrumentation like GFAAS to ensure that the two 
types of Lead Care instruments are reliable. 
 
The IPH has a GFAAS, but it is old, and the company that produced it will no longer provide 
replacement parts or service. Moreover, in many cases, trying to maintain obsolete instruments is 
more expensive in the long run than purchasing new equipment. Therefore, CDC recommends 
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the purchase of a new GFAAS under the EU-MRSI project. A new GFAAS also would allow the 
IPH to become a reference laboratory for Kosovo and perhaps the region. In the meantime, the 
laboratory should continue with proficiency testing and become certified to conduct BLL testing 
by use of the existing equipment as quickly as possible.  
 
Blood Lead Screening 
By December 2010, 45 children had participated in capillary blood lead testing for lead 
poisoning conducted at the Ambulanta in Roma Mahola. The parents of another 12 children from 
8 families have declined testing. The BLLs were analyzed by use of the point-of-care instrument 
Lead Care 1. 
 
Of the 45 children tested by the use of Lead Care 1, 7 (16%) have BLLs ≥ 45 µg/dL, the level at 
which CDC recommends chelation therapy; another 22 (49%) have BLLs 20–44 µg/dL; 11 
(24%) have BLLs 10–19 µg/dL; and 5(11%) children have BLLs < 10 µg/dL.  
 
Three of the 7 children who are potential candidates for chelation therapy had venous BLLs 
drawn in December by a nurse with special training and experience in pediatric phlebotomy. 
This nurse will remain on-call to Ambulanta staff as children who need venous testing present 
themselves for care.  
 
However, the blood of the 3 children has not been analyzed because the Lead Care 1 instrument 
in the Ambulanta stopped working in December and the purchased Lead Care II instrument has 
not been received. If venous BLLs confirm the capillary test, the children will be treated in the 
Ambulanta. Follow-up efforts for the other 4 children have been unsuccessful; the families of 3 
of these 4 children were not home when Mercy Corp and CDC staff conducted home visits, and 
the other child’s parents declined venous testing but will return to the Ambulanta for a capillary 
test. 
 
The 22 children with BLLs 20–44 µg/dL should be retested in 1 month, and if their blood lead 
levels are confirmed by venous testing, the children should be given a multi-vitamin every day. 
We have tentatively scheduled the testing for 10/1/2011 to allow for family notification and to 
accommodate the holiday schedule. A follow-up date of 17/1/2011 has been scheduled for 
children who fail to present on 10/1. 
 
The 11 children with BLLs 10–19 µg/dL should be re-tested in 3 months. If these levels are 
confirmed by venous testing, the children should be given a multi-vitamin every day. We have 
tentatively scheduled the testing for 7/3/2010, with a follow-up date of 14/3/2010 tentatively 
scheduled for children who fail to present on 7/3. 
 
All children whose BLLs are increasing, as determined by the re-testing, should receive home 
visits to evaluate whether lead sources remain in their current environment. Such a review of the 
children’s environment should include consideration of parental occupation and the possible role 
of consumer products—for example, parental metal working and recycling and use of traditional 
remedies or teas and other consumer products. 
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Treatment 
The medical and nursing staff at the Main Family Medicine Center Mitrovicia, Kosovo and the 
Amulanta in Roma Mahalla have received extensive training in the use of the oral chelation 
agent Succimer, following the WHO protocol of two doses a day for 28 days. This protocol has 
also been reviewed and approved in November 2010 by the Kosovo Ministry of Health.  
 
Chelation should begin for the 7 potential candidates as soon as their blood lead levels are 
confirmed by venous blood lead testing. We agreed that the Ambulanta nurses could provide the 
first dose of Succimer in the morning, and if necessary, distribute the multi-vitamin in the 
afternoon. Using the health facilitators who live in Roma Mahalla to distribute the evening dose 
of Succimer is under consideration. However, in most cases, parents could probably administer 
the dose.  
 
Children who are being chelated should have BLLs, urinalysis, and kidney and liver function 
tests on Days 7 and 28 of treatment. They should have blood lead testing 2 weeks and 1 month 
after discontinuation of chelation therapy. These tests could be scheduled when other BLL 
testing is being conducted. 
 
It is very important that the lead poisoning treatment team, the Mercy Corp medical and nursing 
staff, the Family Medicine medical and nursing staff, and the health facilitators meet at least 
every two weeks to review the status of all the cases under care and to plan future screening 
outreach and health education activities. 
 
Outreach and Public Education 
There have been many complaints that families 1) did not receive the results of the blood lead 
tests of their children and 2) do not know what to expect if their child requires chelation therapy. 
In order to address these issues, we agreed that staff of Mercy Corp and the Ministry of Health 
will schedule meeting invitations for families whose children have BLLs 10–44 µg/dL. At such 
meetings, staff will explain a child’s test result and the need for re-testing on the dates tentatively 
scheduled. In addition, the health educator will develop an education module that explains the 
treatment protocol in general terms and incorporate it in his education program. 
 
It is also very important that Rome Mahalla health facilitators and the Mercy Corp staff conduct 
home visits to encourage families to have their children tested. Such visits are particularly 
important in the cases of children who fail to present for screening or follow-up tests. The visits 
will help to identify barriers to testing.  
 
Surveillance 
Three separate line lists currently exist of children less than 6 years old and living in Roma 
Mahalla. The first, DRC/NCA children, consists of those children who were resettled in 2005 
and 2006. The second, RESTART, consists of those children who are being resettled under the 
Mercy Corp RESTART program. The third list, EU-MRSI, contains the names of those children 
who will be resettled under the EU project in 2010 and 2011. It is very important that these lists 
be integrated so that there can be a full accounting of all children relocated to Roma Mahalla. 
Integration of the three lists can help ensure that all these children have been tested for lead and 
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that all their BLLs are recorded. This line listing can serve as the basis of future analyses of the 
children’s lead levels over time. 
 
CDC provided a database program. With Shqipe Agushi’s (Mercy Corps) assistance, CDC will 
provide another version of the database, with data fields and a help file, in Albanian. All children 
and their test results should be entered into this second database to help the staff better keep track 
of the children and their test results and to allow for analyses. The database is also designed to 
collect data about chelation therapy and other treatments for children for whom such treatments 
are necessary.  
 
Reports/Data Management 
The database program can provide reports of blood lead levels by age, gender, and date of test. In 
addition, the data file can easily be uploaded into SAS or another commercial statistical program. 
In the future, Mercy Corps and others may wish to run reports that compare the BLLs of children 
one year after resettlement with their previous BLLs at the time of resettlement, or Mercy Corps 
can compare the BLLs of children born in Roma Mahalla with those of children who were 
relocated. The program can also accommodate description of the BLLs of children who received 
chelation therapy. 
 
Medical records for those children who were treated while living in the IDP camps are now in 
the possession of Mercy Corp. These records should also be entered into the database at some 
point. 
 
Osterode 
Perhaps the most important step to take now to break the cycle of lead poisoning is to make 
Osterode eventually uninhabitable. Osterode, though safer than any of the other camps, still was 
found to have soil that contained unacceptable levels of lead. As families are relocated, the 
containers in which many of them are now living should be moved off the facility. 
Unfortunately, merely sealing these containers may not make them inaccessible. They could be 
inhabited again if many Roma are repatriated from the countries where they fled during the war 
and become homeless in the process. It is also important that Mercy Corps receive back-up in the 
form of security to ensure that new families do not take the place of those relocated and thereby 
continue this terrible tragedy of lead poisoning among the children. 
 
Roma Housing in Roma Mahalla  
The housing in Roma Mahalla is new, and multiple soil testing projects have demonstrated that 
soil lead levels are below UN and US Environmental Protection Agency standards for the safe 
maximum of lead in soil. Unless lead is introduced from outside Roma Mahalla, it is very 
unlikely that the children living there will continue to experience high BLLs.  
 
Most the housing in Roma Mahalla is in excellent condition. However, some houses built under 
RESTART have mold. Mold exposure has been demonstrated by numerous studies to trigger 
asthma attacks in individuals who are sensitive to mold. Therefore, the existing mold needs to be 
cleaned up by use of a mixture of bleach and water, with necessary repairs made so that the 
affected houses will not be vulnerable to mold growth.  
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Continued Support 
CDC will continue to support Mercy Corps and others as needed to address the lead poisoning 
issue. However, at this point the work is well under way, and I am confident that it will be 
successful, given the commitment, energy, and knowledge demonstrated by the Mercy Corp and 
Family Medicine center staff.  
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